Alanood S. Algarni
Impact in
-
- Pharmaceutical Practices and Patient Outcomes
Papers in
-
- Click Chemistry and Applications 3
- Synthesis and biological activity 2
- Co-authors
- Nasser M. Alorfi (5 shared papers)Ashraf N. Abdalla (9 shared papers)Asaad Khalid (7 shared papers)Alan J. Hargreaves (3 shared papers)John M. Dickenson (2 shared papers)Long Chiau Ming (2 shared papers)Abdelhakim Bouyahya (2 shared papers)Mohammad Ali Shariati (1 shared paper)
- Journals
- Biomedicine & Pharmacotherapy (2 papers)Frontiers in Pharmacology (2 papers)Applied Microbiology and Biotechnology (1 paper)Pharmaceuticals (1 paper)Critical Reviews in Food Science and Nutrition (1 paper)
- Partner nations
- Saudi ArabiaPakistanSudan
In The Last Decade
Alanood S. Algarni
26 papers receiving 269 citations
Peers
Comparison fields: 5 of 80
- Geriatrics and Gerontology 11
- Toxicology 8
- Biochemistry 14
- Pharmacology 30
- Pharmaceutical Science 11
Countries citing papers authored by Alanood S. Algarni
This map shows the geographic impact of Alanood S. Algarni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alanood S. Algarni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alanood S. Algarni more than expected).
Fields of papers citing papers by Alanood S. Algarni
This network shows the impact of papers produced by Alanood S. Algarni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alanood S. Algarni. The network helps show where Alanood S. Algarni may publish in the future.
Co-authors
The 25 scholars most cited alongside Alanood S. Algarni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 35 | |
| 2 | 2023 | 25 | |
| 3 | 2022 | 24 | |
| 4 | 2022 | 20 | |
| 5 | 2021 | 17 | |
| 6 | 2022 | 15 | |
| 7 | 2021 | 15 | |
| 8 | 2017 | 13 | |
| 9 | 2023 | 13 | |
| 10 | 2022 | 11 | |
| 11 | 2023 | 10 | |
| 12 | 2023 | 9 | |
| 13 | 2024 | 9 | |
| 14 | 2024 | 8 | |
| 15 | 2023 | 8 | |
| 16 | 2022 | 6 | |
| 17 | 2017 | 6 | |
| 18 | 2024 | 5 | |
| 19 | 2025 | 5 | |
| 20 | 2020 | 5 |
About Alanood S. Algarni
Alanood S. Algarni is a scholar working on Organic Chemistry, Molecular Biology, Pulmonary and Respiratory Medicine, Computational Theory and Mathematics and Pharmacology, having authored 29 papers that have together received 276 indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (5 papers), Click Chemistry and Applications (3 papers), Cholinesterase and Neurodegenerative Diseases (3 papers), Blood properties and coagulation (3 papers), Substance Abuse Treatment and Outcomes (2 papers), Ginger and Zingiberaceae research (2 papers), Pharmaceutical studies and practices (2 papers) and Synthesis and biological activity (2 papers). The work is most often cited by research in Geriatrics and Gerontology (11 citations), Toxicology (8 citations), Biochemistry (14 citations), Pharmacology (30 citations) and Pharmaceutical Science (11 citations). Alanood S. Algarni has collaborated with scholars based in Saudi Arabia, Pakistan and Sudan. Frequent co-authors include Nasser M. Alorfi, Ashraf N. Abdalla, Asaad Khalid, Alan J. Hargreaves, John M. Dickenson, Long Chiau Ming, Abdelhakim Bouyahya, Mohammad Ali Shariati, Saad Bakrim and Gökhan Zengin. Their work appears in journals such as Biomedicine & Pharmacotherapy, Frontiers in Pharmacology, Applied Microbiology and Biotechnology, Pharmaceuticals and Critical Reviews in Food Science and Nutrition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.